The SITC 2017 Microlearning: Additional Topics Series has been developed with content from abstract and faculty presentations conducted at the Society for Immunotherapy of Cancer 32nd Annual Meeting (SITC 2017). The microlearning series provide a quick, easily accessible format for clinicians and researchers to learn about the latest advances in cancer immunotherapy from experts in the field.
The SITC 2017 Microlearning: Additional Topics series contains three modules.
Module 1: Genetically Modified T Cells for Solid Tumors
Stephen Gottschalk, MD - St. Jude Children's Research Hospital
Module 2: Improvement in Epitope Discovery
Catherine J. Wu, MD - Dana-Farber Cancer Institute
Module 3: Identification of Unique Neoantigen Qualities in Long-Term Pancreatic Cancer Survivors
Vinod Balachandran, MD - Memorial Sloan Kettering Cancer Center
These modules have been designed to meet the educational needs of researchers and healthcare professionals involved in cancer research and clinical care.
Course Available Beginning: August 16, 2018
Upon completion of this activity, participants will be able to:
- Explain strategies to identify cancer-specific epitopes for therapeutic use.
- Describe strategies concerning modification of T cells to increase tumor targeting.
- Define how cancer-specific markers may predict duration of response with immunotherapy.